Skip to main content
. Author manuscript; available in PMC: 2016 Nov 28.
Published in final edited form as: AIDS. 2015 Jul;29(Suppl 2):S129–S136. doi: 10.1097/QAD.0000000000000713

Table 1.

ICAP’s Core Interventions.

Core Intervention Components
HIV testing and counselling Includes provider-initiated testing and counseling (PITC) and testing for partners and
  family members
Linkage to HIV care for those testing positive for HIV Linkage from all HIV testing entry points
Cotrimoxazole (CTX) prophylaxis CTX prophylaxis for all eligible people living with HIV (PLWH)
Tuberculosis screening Regular screening with a symptom-based checklist
Additional evaluation and treatment for those who screen positive
Isoniazid preventive therapy (IPT) for those who screen negative
Assessment of ART eligibility, with prompt ART
  initiation, if eligible
WHO staging at every visit, including assessment and treatment of opportunistic
  illnesses
Monitoring of child growth and development
CD4+ testing at enrollment in care and every 6 months thereafter
Prevention of mother-to-child transmission of HIV Family planning services to prevent unintended pregnancy
ART for all pregnant and breastfeeding women with HIV
Prompt provision of antiretroviral and other prophylaxis at birth
Ongoing care for HIV-infected mothers and HIV-exposed infants
Medication monitoring and management Monitoring of medication adherence & provision of adherence support
Monitoring for and management of medication-related side effects and toxicity
Monitoring for treatment response and treatment failure, with regimen adjustment, as
  needed
Monitoring and supporting retention in HIV care Appointment reminders
Monitoring of appointment attendance
Community-based patient groups for ART refills
Outreach and tracking of those who miss appointments and/or are lost to follow-up
Access to laboratory testing for HIV diagnosis,
  determining ART eligibility, monitoring treatment
  response, and diagnosing TB
HIV diagnosis including rapid HIV testing and dried blood spot-based HIV-1 DNA PCR
  for early infant diagnosis
CD4+ T-cell testing for assessing ART eligibility and monitoring treatment response
Routine or targeted viral load monitoring to detect treatment failure, if available
Microscopic or molecular TB diagnosis
Psychosocial support Patient education
Counseling to support disclosure, manage stigma and discrimination
Support groups
Financial support and microfinance projects

ART, antiretroviral therapy; TB, tuberculosis.